![Amy Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Levin
Hoofd Techniek/Wetenschap/O&O bij
ONCOLYTICS BIOTECH INC.
Vermogen: 32 056 $ op 31-08-2026
Profiel
Amy Levin currently works at Oncolytics Biotech, Inc., as Vice President-Clinical Operations from 2020.
Ms. Levin also formerly worked at Puma Biotechnology, Inc., as Senior Director-Clinical Operations from 2011 to 2020 and Janssen Oncology, Inc., as Director-Clinical Program Leader from 2007 to 2011.
Ms. Levin received her undergraduate degree from The University of Texas at Austin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-12-2025 | 38.253 ( 0,03% ) | 32 056 $ | 31-08-2026 |
Actieve functies van Amy Levin
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2020 |
Eerdere bekende functies van Amy Levin
| Bedrijven | Functie | Einde |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2020 |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Corporate Officer/Principal | 01-12-2011 |
Opleiding van Amy Levin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
53
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
